Ignite Creation Date:
2025-12-24 @ 4:13 PM
Ignite Modification Date:
2025-12-24 @ 4:13 PM
Study NCT ID:
NCT02070666
Status:
TERMINATED
Last Update Posted:
2020-06-19
First Post:
2014-02-19
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Preventive Strategies in Acute Respiratory Distress Syndrome (ARDS)
Sponsor:
Corporacion Parc Tauli
Organization:
Study Overview
Official Title:
Preventive Strategies in Acute Respiratory Distress Syndrome
Status:
TERMINATED
Status Verified Date:
2020-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Low recruitment and published data with no benefit
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
EPALI
Brief Summary:
The investigators hypothesis is that patients at risk of ARDS, detected by LIPS (Lung Injury Prediction Score), under mechanical ventilation could benefit from a protective ventilatory strategy (used in ARDS treatment) in order to avoid or decrease the ARDS development. This would lead to a decrease in incidence, mortality and health care costs associated to this syndrome.
This study will help to confirm the current evidence about low tidal volumes, evaluating adverse events of this strategy.
This study will help to confirm the current evidence about low tidal volumes, evaluating adverse events of this strategy.
Detailed Description:
The main objective is to evaluate the effect of a protective ventilatory strategy by using lower tidal volumes compared to the use of traditionally volumes in ARDS development.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: